tiprankstipranks
Medicure Inc (TSE:MPH)
:MPH
Holding TSE:MPH?
Track your performance easily

Medicure (MPH) Stock Price & Analysis

5 Followers

MPH Stock Chart & Stats


Financials

Annual

Options Prices

Currently, No data available
---

Ownership Overview

24.73%75.27%
24.73% Insiders
― Other Institutional Investors
75.27% Public Companies and
Individual Investors

MPH FAQ

What was Medicure Inc’s price range in the past 12 months?
Medicure Inc lowest stock price was C$0.81 and its highest was C$1.45 in the past 12 months.
    What is Medicure Inc’s market cap?
    Medicure Inc’s market cap is C$9.39M.
      When is Medicure Inc’s upcoming earnings report date?
      Medicure Inc’s upcoming earnings report date is Apr 16, 2025 which is in 87 days.
        How were Medicure Inc’s earnings last quarter?
        Medicure Inc released its earnings results on Nov 25, 2024. The company reported C$0.065 earnings per share for the quarter, beating the consensus estimate of N/A by C$0.065.
          Is Medicure Inc overvalued?
          According to Wall Street analysts Medicure Inc’s price is currently Overvalued. Get more investment ideas with TipRanks Premium
            Does Medicure Inc pay dividends?
            Medicure Inc does not currently pay dividends.
            What is Medicure Inc’s EPS estimate?
            Medicure Inc’s EPS estimate for its next earnings report is not yet available.
            How many shares outstanding does Medicure Inc have?
            Medicure Inc has 10,436,313 shares outstanding.
              What happened to Medicure Inc’s price movement after its last earnings report?
              Medicure Inc reported an EPS of C$0.065 in its last earnings report, beating expectations of N/A. Following the earnings report the stock price went up 10%.
                Which hedge fund is a major shareholder of Medicure Inc?
                Currently, no hedge funds are holding shares in TSE:MPH
                ---

                Company Description

                Medicure Inc

                Medicure Inc is a specialty pharmaceutical company. It is involved in research, clinical development, and commercialization of human therapeutics for United States hospital market. Its main focus is on sale and marketing of its drug Aggrastat which is a glycoprotein GP IIb/IIIa receptor antagonist, is used for the treatment of acute coronary syndrome including unstable angina. The firm derives the majority of its revenue geographically from the United States.
                ---
                Similar Stocks
                Company
                Price & Change
                Follow
                Revive Therapeutics
                Hemostemix
                Quest Pharmatech
                Popular Stocks
                ---
                What am I Missing?
                Make informed decisions based on Top Analysts' activity
                Know what industry insiders are buying
                Get actionable alerts from top Wall Street Analysts
                Find out before anyone else which stock is going to shoot up
                Get powerful stock screeners & detailed portfolio analysis